bortezomib

Frequently asked questions

What does Bortezomib treat?

Bortezomib (Bortezomib) may be used to treat multiple myeloma, mantle-cell lymphoma, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.

Is there a coupon or discount for Bortezomib?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Bortezomib. To pay less, Bortezomib is already a generic — usually the lowest-cost version — so the main levers are comparing cash prices between pharmacies and using a pharmacy discount-card service. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Bortezomib?

Bortezomib is marketed by Accord Hlthcare. You can see Accord Hlthcare's full profile, rating, and other products on pharmaranks.

Is Bortezomib a brand-name or generic drug?

Bortezomib is a generic medication; its active ingredient is Bortezomib. Generics contain the same active ingredient as the brand-name original and are usually lower cost.

Is Bortezomib available over the counter?

No. Bortezomib is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Bortezomib come in?

Bortezomib is currently marketed as injectable and powder, per the FDA's National Drug Code Directory.

What class of drug is Bortezomib?

Bortezomib is classified as proteasome inhibitor, per the FDA's Established Pharmacologic Class.

Is Bortezomib FDA-registered?

Bortezomib is on record with the U.S. FDA under application number ANDA204405. You can verify this on its official FDA label.